Avricore Health Inc is making waves on the TSXV with a remarkable 7.69% surge in stock price, closing at CA$0.07.
In today's trading session, Avricore Health Inc (AVCR.V) has caught the attention of investors with a notable increase in its stock price. This rise comes as the company continues to expand its efforts, particularly in the UK market.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$7.58M
52W high
$0.10
52W low
$0.04
1W change
+18.18%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
131.9%
Annualized
90-Day Vol
110.3%
Annualized
Trend (90d)
-31.1%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.10 |
| 60 trading days | C$0.06 | C$0.03 – C$0.11 |
| 90 trading days | C$0.06 | C$0.03 – C$0.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on Avricore Health's strategic moves as it expands its HealthTab™ platform, which could lead to further growth and profitability in the future.
7.69% Gain in One Day
Avricore Health Inc's stock price increased from CA$0.065 to CA$0.07, reflecting strong positive sentiment among investors.
Bull case
The recent financing of CA$1.254 million shows strong investor confidence and provides the capital Avricore needs for its expansion plans, which could significantly boost its market presence.
Bear case
Despite today's gains, Avricore Health's profitability is still uncertain, with a profit margin of 0% and no dividends, which might discourage risk-averse investors.
Positive Momentum in Stock Performance
Avricore Health Inc's stock has seen a notable increase of 7.69% in the last trading session, closing at CA$0.07. This surge reflects growing interest in the company's innovative HealthTab™ platform, designed to enhance point-of-care testing in community pharmacies.
Strategic Expansion Plans
The recent financing of CA$1.254 million is a significant milestone for Avricore Health, providing essential funds to support its expansion initiatives in the UK. The company aims to broaden its HealthTab™ platform's reach, which has already screened over 3,500 patients, indicating strong demand for its services.
Future Outlook
As Avricore Health continues to innovate and expand its market presence, investors will want to monitor its financial performance and strategic developments. The company's ability to turn its growth initiatives into profitability will be crucial for maintaining investor confidence.
Advertisement
